Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin Prophylaxis in Groin Hernioplasty
NCT07111702Completed
- Sponsor
- Sana'a University
- Start
- Oct 2023
- Primary completion
- May 2024
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Open-label trial of cefazolin in surgical site infection (SSI) (2 arms), sponsored by Sana'a University. Primary endpoint: Incidence of Surgical Site Infection at 30 days. Started Oct 2023; status: completed.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT07111702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07111702.